CUSIP: 42225K106
Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM CL A
-
Total 13F shares
-
8,179,277
-
Share change
-
+4,359,773
-
Total reported value
-
$130,866,000
-
Price per share
-
$16.00
-
Number of holders
-
76
-
Value change
-
+$69,626,562
-
Number of buys
-
56
-
Number of sells
-
20
Quarterly Holders Quick Answers
What is CUSIP 42225K106?
CUSIP 42225K106 identifies HIIQ - HEALTH INS INNOVATIONS INC - COM CL A in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2017
-
Previous quarter:
Q4 2016
Recent filing periods for CUSIP 42225K106:
Institutional Holders of HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) as of Q1 2017
As of 31 Mar 2017,
HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,179,277 shares.
The largest 10 holders included
CANNELL CAPITAL LLC, RENAISSANCE TECHNOLOGIES LLC, Lyon Street Capital, LLC, DIALECTIC CAPITAL MANAGEMENT, LP, VANGUARD GROUP INC, EMERALD MUTUAL FUND ADVISERS TRUST, Alyeska Investment Group, L.P., Cortina Asset Management, LLC, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.